We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

News

News

Cell Technology Used to Treat Osteochondral Knee Defect

Autologous cells of stromal vascular fraction were transplanted to a 36-year-old man with the use of fibrin matrix.
News

Chemists Design 'Mini-ecosystems' to Test Drug Function

Scripps Research scientists have solved a major problem in chemistry and drug development by using droplet-sized 'miniecosystems' to quickly see if a molecule can function as a potential therapeutic.
News

Novel Method for Testing Vaccine Safety

Scientists from the Institut Pasteur, the CNRS and Sanofi Pasteur have recently developed a novel alternative method to animal testing that can be used to verify the safety of vaccines such as the yellow fever vaccine.
News

Recruiting Microbes to Combat Cholera Infection

MIT engineers have developed a probiotic mix of natural and engineered bacteria to diagnose and treat cholera, an intestinal infection that causes severe dehydration.
News

Sartorius Stedim Biotech and Siemens Sign Automation Agreement

Siemens becomes a preferred supplier for automation solutions. Product portfolio of Sartorius Stedim Biotech to feature a globally standardized automation platform in the future.
News

Vaccine Based on Spider Silk

By successfully encapsulating a vaccine into a spider silk microparticle researchers have discovered a novel technique that will help fight cancer and certain infectious diseases.
News

Treg Cells Protect Babies from Getting HIV Infection from their Mothers

Treg cells, a type of regulatory lymphocyte, may be protecting babies in the womb from getting infected with the HIV virus when the mother is infected.
News

Microbiotica Enters into Microbiome Collaboration with Genentech

Strategic collaboration for microbiome biomarker signatures and therapeutic discovery based on Genentech’s inflammatory bowel disease pipeline.
News

Breaking Through a Tumor’s Defenses

Researchers have shown that some tumors use not one but two levels of protection against the immune system. Knocking out one level boosted the protective effects of the second and vice versa. A two-pronged approach targeting both cell types simultaneously may offer a promising route for the development of new cancer immunotherapies.
News

What Motivates People to Donate Their Poop to Medicine?

Fecal microbiota transplant (FMT) is widely regarded as the most effective treatment for a dangerous intestinal infection known as Clostridium difficile (C. diff). Appealing to a concern for others is the best way to recruit most people to donate their stool for medicine, while cash rewards may be an additional motivator for some potential donors, according to new research.
Advertisement